Dr. William A. Haseltine
Cloning antibodies from recovered COVID-19 patients is showing promise as a potential treatment for the virus that has affected more than 2.8 million people worldwide and killed at least 196,000.
Dr. William A. Haseltine, Chair and President of ACCESS Health International and former Harvard Medical School professor, told uPolitics that an antibody drug could be approved in the U.S. within four months.
Following Vice President JD Vance's tie-breaking vote in the Senate, President Donald Trump's "Big, Beautiful…
President Donald Trump has repeatedly attacked New York City Democratic mayoral nominee Zohran Mamdani since…
Secretary of Homeland Security Kristi Noem allegedly took $80,000 in political donations while serving as…
According to financial documents released in early June, President Donald Trump has profited immensely from…
The Trump Administration plans to ease gun regulations by restructuring the Bureau of Alcohol, Tobacco,…
The U.S. Senate approved President Donald Trump’s “Big, Beautiful Bill” by a vote of 51-50,…